Your browser doesn't support javascript.
loading
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Dytfeld, Dominik; Wróbel, Tomasz; Jamroziak, Krzysztof; Kubicki, Tadeusz; Robak, Pawel; Walter-Croneck, Adam; Czyz, Jaroslaw; Tyczynska, Agata; Druzd-Sitek, Agnieszka; Giannopoulos, Krzysztof; Nowicki, Adam; Szczepaniak, Tomasz; Lojko-Dankowska, Anna; Matuszak, Magdalena; Gil, Lidia; Pula, Bartosz; Rybka, Justyna; Majcherek, Maciej; Usnarska-Zubkiewicz, Lidia; Szukalski, Lukasz; Konska, Agnieszka; Zaucha, Jan Maciej; Walewski, Jan; Mikulski, Damian; Czabak, Olga; Robak, Tadeusz; Lahoud, Oscar B; Zonder, Jeffrey A; Griffith, Kent; Stefka, Andrew; Major, Ajay; Derman, Benjamin A; Jakubowiak, Andrzej J.
Afiliación
  • Dytfeld D; Poznan University of Medical Sciences, Poznan, Poland.
  • Wróbel T; Wroclaw Medical University, Wroclaw, Poland.
  • Jamroziak K; Institute of Hematology and Blood Transfusion, Warsaw, Poland.
  • Kubicki T; Poznan University of Medical Sciences, Poznan, Poland.
  • Robak P; Medical University of Lodz, Lodz, Poland.
  • Walter-Croneck A; Medical University of Lublin, Lublin, Poland.
  • Czyz J; Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
  • Tyczynska A; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Druzd-Sitek A; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Giannopoulos K; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Nowicki A; Poznan University of Medical Sciences, Poznan, Poland.
  • Szczepaniak T; Poznan University of Medical Sciences, Poznan, Poland.
  • Lojko-Dankowska A; Poznan University of Medical Sciences, Poznan, Poland.
  • Matuszak M; Poznan University of Medical Sciences, Poznan, Poland.
  • Gil L; Poznan University of Medical Sciences, Poznan, Poland.
  • Pula B; Poznan University of Medical Sciences, Poznan, Poland.
  • Rybka J; Wroclaw Medical University, Wroclaw, Poland.
  • Majcherek M; Wroclaw Medical University, Wroclaw, Poland.
  • Usnarska-Zubkiewicz L; Wroclaw Medical University, Wroclaw, Poland.
  • Szukalski L; Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
  • Konska A; Institute of Hematology and Blood Transfusion, Warsaw, Poland.
  • Zaucha JM; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.
  • Walewski J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Mikulski D; Medical University of Lodz, Lodz, Poland.
  • Czabak O; Medical University of Lublin, Lublin, Poland.
  • Robak T; Medical University of Lodz, Lodz, Poland.
  • Lahoud OB; Memorial Sloan-Kettering Cancer Institute, New York, NY, USA.
  • Zonder JA; Karmanos Cancer Institute, Detroit, MI, USA.
  • Griffith K; University of Michigan, Ann Arbor, MI, USA.
  • Stefka A; University of Chicago Medical Center, Chicago, IL, USA.
  • Major A; University of Chicago Medical Center, Chicago, IL, USA; University of Colorado School of Medicine, Aurora, CO, USA.
  • Derman BA; University of Chicago Medical Center, Chicago, IL, USA.
  • Jakubowiak AJ; University of Chicago Medical Center, Chicago, IL, USA. Electronic address: ajakubowiak@medicine.bsd.uchicago.edu.
Lancet Oncol ; 24(2): 139-150, 2023 02.
Article en En | MEDLINE | ID: mdl-36642080

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Polonia